USANA Health Sciences, Inc. (USNA)
NYSE · Consumer Defensive · Packaged Foods
$14.85+0.20%as of Oct 6, 2026, 7:35 AM ET
- Market cap
- $274M
- Forward P/E
- 8.4
- 52-week range
- $12.57 – $26.76
- 52-week change
- −43.71%
- EPS (trailing)
- −$1.20
- Next earnings
- Oct 21, 2026
Fiscal year to Jan 2026
- Revenue
- $925M (+8.28%)
- Net income
- $10.8M
- Operating margin
- 4.0%
- Diluted EPS
- $0.58
- Free cash flow
- $8.5M
From the company’s annual report on SEC EDGAR.
About USANA Health Sciences, Inc.
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
Headquarters: Salt Lake City, United States · 1,570 employees · usana.com